Publication | Closed Access

Growth hormone administration reduces circulating proinflammatory cytokines and soluble Fas/soluble Fas ligand system in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy

CardiomyopathyHeart FailureChronic Heart FailureCardiorenal SyndromesCardiovascular DiseaseGrowth HormonePhysiologyAdministration ReducesMedicineCardiology